Diamond Edge Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
BO Materials develops novel materials for industrial applications across trillion-dollar industries.
AI & Machine LearningDeep TechNew MaterialsSemiconductorsMassachusetts, US
Michael Segal(Executive Officer, Director)inAnvesh Gurijala(Executive Officer, Director)
BoardDavid Miller(Director)inDwight Poler(Director)Andrew Goldman(Director)
Co-investorsAccelr8ACVC PartnersClean Energy VentureClean Energy VenturesCollaborative FundGood Growth Capital+4 more
Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases.
BiotechDeep TechDundee, GB
Satpal Virdee(Founder)
Co-investorsM VenturesMC Healthcare Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.